Biolife Solutions (BLFS) Cash from Financing Activities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash from Financing Activities data on file, last reported at -$7.9 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 163.87% year-over-year to -$7.9 million in Q1 2026; TTM through Mar 2026 was -$15.8 million, a 79.38% decrease from a year earlier, with the FY2025 full-year figure at -$10.9 million, down 61.05% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$7.9 million, down from -$2.5 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for BLFS reached as high as $17.4 million in Q3 2022 and fell as low as -$7.9 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged $76764.7 across 5 years, with a median of -$704000.0 in 2024.
• Across the five-year window, Cash from Financing Activities surged 1745.65% in 2022 and slumped 308.81% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$625000.0 in 2022, then jumped by 1674.56% to $9.8 million in 2023, then plunged by 141.52% to -$4.1 million in 2024, then jumped by 38.91% to -$2.5 million in 2025, then tumbled by 216.31% to -$7.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$7.9 million in Q1 2026, -$2.5 million in Q4 2025, and -$2.6 million in Q3 2025.